Why it was recalled
Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.
Product description
Citalopram tablets USP, 20mg, 30-count bottle, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Bachupalli, India 502 325, NDC 55111-343-30
Lot numbers, UPCs & expiration codes
Lot #: C201922, Exp 1/14
Where it was sold
Nationwide
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-179-2013
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Aug 1, 2012
- FDA report date
- Mar 6, 2013
- Quantity
- 86, 093 bottles
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Dr. Reddy's Laboratories, Inc.
Original FDA data
Every field from FDA enforcement report D-179-2013, exactly as published.
Show all FDA fields
- City
- Bridgewater
- State
- NJ
- Status
- Terminated
- Country
- United States
- Event ID
- 63285
- Address
- 200 Somerset Corporate Blvd Fl 7th
- Code information
- Lot #: C201922, Exp 1/14
- Postal code
- 08807-2862
- Report date
- Mar 6, 2013
- Product type
- Drugs
- Recall number
- D-179-2013
- Classification
- Class II
- Recalling firm
- Dr. Reddy's Laboratories, Inc.
- Product quantity
- 86, 093 bottles
- Termination date
- May 24, 2013
- Reason for recall
- Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Citalopram tablets USP, 20mg, 30-count bottle, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Bachupalli, India 502 325, NDC 55111-343-30
- Distribution pattern
- Nationwide
- Recall initiation date
- Aug 1, 2012
- Initial firm notification
- Letter
- Center classification date
- Feb 28, 2013